Publikationen von Huttner, Michael
(ORCID: 0000-0002-3766-5909)

Lippl, Jonas, Reinke, Sarah , Koch, Karoline, Oschlies, Ilske, Schrod, Stefan, Wolfseher, Lukas, Hüttl, Paul , Huttner, Michael , Beà, Silvia, Campo, Elias, Ladetto, Marco, Cogliatti, Sergio, Ehinger, Mats, Rymkiewicz, Grzegorz, Tabanelli, Valentina, Rauert-Wunderlich, Hilka, Rosenwald, Andreas, Spang, Rainer , Hoster, Eva, Dreyling, Martin, Altenbuchinger, Michael, Klapper, Wolfram, Pott, Christiane, Klener, Pavel, Jerkeman, Mats, Hess, Georg, Cordero, Francesca, Ek, Sara, Ferrero, Simone und Ginè, Eva (2026) Mantle cell lymphoma artificial intelligence prognostic index using hematoxylin and eosin histology. Leukemia.

Simeth, Jakob , Hüttl, Paul , Schön, Marian, Nozari, Zahra, Huttner, Michael , Schmidt, Tobias, Altenbuchinger, Michael und Spang, Rainer (2024) Virtual Tissue Expression Analysis. Bioinformatics, btae709.

Huttner, Michael (2024) Infrastructure for digital medicine and AI enhanced pathology. Dissertation, Universität Regensburg.

Staiger, A. M., Altenbuchinger, Michael, Ziepert, M., Kohler, Christian, Horn, H., Huttner, Michael , Huttl, K. S., Glehr, Gunther , Klapper, W., Szczepanowski, M., Richter, J., Stein, H., Feller, A. C., Moller, P., Hansmann, M. L., Poeschel, V., Held, G., Loeffler, M., Schmitz, N., Trumper, L., Pukrop, T., Rosenwald, A., Ott, G., Spang, Rainer , Emed Demonstrator Project, und German High Grade Non-Hodgkin’s Lymphoma Study Group (DSHNHL), (2019) A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHL. Leukemia 34, S. 543-552. Volltext nicht vorhanden.